THUREN; Tom

Patent Applications and Registrations

Patent applications and USPTO patent grants for THUREN; Tom.The latest application filed is for "method for reducing the risk of a cardiovascular event with conjugated antisense compounds targeting apo(a)".

Company Profile

5.7.15

THUREN; Tom - Succasunna NJ
Thuren; Tom - East Hanover NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Reducing The Risk Of A Cardiovascular Event With Conjugated Antisense Compounds Targeting Apo(a) App 20210395737 - LESOGOR; Anastasia ; et al.	2021-12-23
Use of IL-1 beta Binding Antibodies App 20210371512 - THUREN; Tom ; et al.	2021-12-02
Use Of Il-1 Beta Binding Antibodies For Treating Peripheral Arterial Disease App 20210317202 - BASSON; Craig ; et al.	2021-10-14
Methods of reducing the risk of experiencing a cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered a qualifying CV event Grant 10,975,145 - Thuren , et al. April 13, 2	2021-04-13
Use Of Canakinumab App 20200239564 - RIDKER; Paul ; et al.	2020-07-30
Use Of Canakinumab App 20200199220 - THUREN; Tom ; et al.	2020-06-25
Use Of Il-1 Beta Binding Antibodies For Treating Peripheral Arterial Disease App 20200148759 - Basson; Craig ; et al.	2020-05-14
USE OF IL-1beta BINDING ANTIBODIES App 20190048072 - Ligueros-Saylan; Monica ; et al.	2019-02-14
Use Of Il-1 Beta Binding Antibodies For Treating Peripheral Arterial Disease App 20180258166 - Basson; Craig ; et al.	2018-09-13
Use of IL-1 .beta. binding antibodies for treating peripheral arterial disease Grant 10,000,565 - Basson , et al. June 19, 2	2018-06-19
Use of IL-1 Binding Antibodies App 20170275358 - Thuren; Tom ; et al.	2017-09-28
Methods of reducing the risk of experiencing a cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered a qualifying CV event Grant 9,683,038 - Thuren , et al. June 20, 2	2017-06-20
Use Of Il-1 Beta Binding Antibodies For Treating Peripheral Arterial Disease App 20160326243 - Basson; Craig ; et al.	2016-11-10
Uses of DGAT1 inhibitors Grant 9,061,012 - Meyers , et al. June 23, 2	2015-06-23
Use of IL-1 beta Binding Antibodies App 20140356356 - Thuren; Tom ; et al.	2014-12-04
Uses Of Dgat1 Inhibitors App 20130023495 - Meyers; Charles ; et al.	2013-01-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.